Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in kids and adults . In Canada, its distribution is managed by Health Canada. This https://sandoz-lisdexamfetamine-175015.suomiblog.com/vyvanse-in-canada-a-complete-guide-59053248